Congratulations, Lara!

We are grateful to the Damon Runyon Cancer Foundation and the St Baldrick's Foundation for their combined support of our Adolescent and Young Adult (AYA) oncology fellow, Lara Davis, in pursuit of her project for Personalized Osteosarcoma Therapy in man and dog.  Lara's studies are in collaboration with a team at Oregon State University, led by Dr. Bernard Seguin.  This work was made possible by an initial pilot grant from the Thrasher Foundation as well as longstanding, ongoing support from community of Tulsa, Oklahoma, and Carter family who drive the Scott Carter Foundation.  Scott is a young man for which this project was created... he lost his battle to osteosarcoma in 1993, but his vision of better treatments through research has inspired us find better ways to treat relapsed or newly diagnosed sarcomas.  

  

Our thanks to CureSearch!

We are grateful to CureSearch for Children's Cancer for the $40,000 grant to pursue our proposal, COG-STS Preclinical Targeted Agent Trial Design Support.  Through this project we will provide the Children's Oncology Group Soft Tissue Sarcoma committee with real-time testing of a targeted therapeutic for rhabdomyosarcoma and non-rhabdomyosarcoma soft tissue sarcomas.     
  

Congratulations, Jinu!

Congratulations to Jinu whose paper addressing receptor tyrosine kinase inhibitor resistance was accepted today to Biochemical and Biophysical Research Communications.  Co-authors of the study include Jason Glover, Jeff Tyner, Marc Loriaux from the laboratory of Brian Druker, Keller lab alumni Aoife Kilcoyne, Laura Nelon and Corrine Chua, as well as Texas collaborators Ranadip Pal, Jennifer Carew, Yongjian Ouyang and Joel Michalek, Cleveland Clinic collaborator Brian Rubin and Ireland collaborator Frank Giles.  
  
[ 08/21/12:  "An adaptive Src–PDGFRA–Raf axis in rhabdomyosarcoma", now online here ! ]